Lineage Cell Therapeutics, Inc. (LCTX)
NYSEAMERICAN: LCTX · IEX Real-Time Price · USD
1.080
+0.020 (1.89%)
May 17, 2024, 4:00 PM EDT - Market closed

Lineage Cell Therapeutics Stock Forecast

Stock Price Forecast

The 2 analysts with 12-month price forecasts for LCTX stock have an average target of 6.50, with a low estimate of 6.00 and a high estimate of 7.00. The average target predicts an increase of 501.85% from the current stock price of 1.08.

Analyst Consensus: Strong Buy
Target Low Average Median High
Price $6.00 $6.50 $7.00 $7.00
Change +455.56% +501.85% +548.15% +548.15%

Analyst Ratings

The average analyst rating for LCTX stock from 2 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating Dec '23Jan '24Feb '24Mar '24Apr '24May '24
Strong Buy 111111
Buy 221111
Hold 000000
Sell 000000
Strong Sell 000000
Total 332222

Latest Forecasts

Analyst Firm Rating Rating Action Price Target Upside Date
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$7
Strong Buy Reiterates $7 +548.15% May 6, 2024
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$7
Strong Buy Reiterates $7 +548.15% Mar 8, 2024
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$7
Strong Buy Reiterates $7 +548.15% Feb 13, 2024
Cantor Fitzgerald
Cantor Fitzgerald
Buy
Reiterates
$6
Buy Reiterates $6 +455.56% Feb 5, 2024
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$7
Strong Buy Reiterates $7 +548.15% Aug 11, 2023
More Analyst Ratings

Financial Forecast

Revenue This Year
17.83M
from 8.95M
Increased by 99.33%
Revenue Next Year
17.84M
from 17.83M
Increased by 0.06%
EPS This Year
-0.12
from -0.12
EPS Next Year
-0.13
from -0.12
Year 2019202020212022202320242025202620272028
Revenue
3.52M1.83M4.34M14.70M8.95M17.83M17.84M45.10M70.41M153.09M
Revenue Growth
-29.53%-48.05%137.73%238.70%-39.16%99.33%0.06%152.77%56.14%117.42%
EPS
-0.08-0.14-0.26-0.15-0.12-0.12-0.13-0.12-0.14-0.12
EPS Growth
----------
No. Analysts -----87633
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue 20242025202620272028
High 47.3M 52.5M 98.4M 178.2M 335.7M
Avg 17.8M 17.8M 45.1M 70.4M 153.1M
Low n/a 2.5M 3.3M 3.3M 3.3M

Revenue Growth

Revenue Growth 20242025202620272028
High
428.2%
194.4%
451.4%
295.2%
376.7%
Avg
99.3%
0.1%
152.8%
56.1%
117.4%
Low -
-85.7%
-81.6%
-92.7%
-95.3%

EPS Forecast

EPS 20242025202620272028
High -0.01 -0.03 0.06 -0.15 -0.13
Avg -0.12 -0.13 -0.12 -0.14 -0.12
Low -0.22 -0.23 -0.20 -0.14 -0.12

EPS Growth

EPS Growth 20242025202620272028
High - - - - -
Avg - - - - -
Low - - - - -
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.